Renentech Laboratories Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 06-07-2024
- Paid Up Capital ₹ 0.10 M
as on 06-07-2024
- Company Age 32 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 16.68%
(FY 2023)
- Profit 3.94%
(FY 2023)
- Ebitda 2.14%
(FY 2023)
- Net Worth 26.66%
(FY 2023)
- Total Assets 19.56%
(FY 2023)
About Renentech Laboratories
The Company is engaged in the Travel And Hospitality Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Anita Jakhete and Prashant Jakhete serve as directors at the Company.
- CIN/LLPIN
U24100MH1992PTC066259
- Company No.
066259
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
08 Apr 1992
- Date of AGM
01 Aug 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
What products or services does Renentech Laboratories Private Limited offer?
Renentech Laboratories Private Limited offers a wide range of products and services, including ISO & Quality Management Consultants, Quality Assurance Service.
Who are the key members and board of directors at Renentech Laboratories?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anita Jakhete  | Director | 29-Jan-2001 | Current |
| Prashant Jakhete | Director | 08-Apr-1992 | Current |
Financial Performance and Corporate Structure Insights of Renentech Laboratories.
Renentech Laboratories Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.68% increase. The company also saw a slight improvement in profitability, with a 3.94% increase in profit. The company's net worth Soared by an impressive increase of 26.66%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Renentech Laboratories?
In 2023, Renentech Laboratories had a promoter holding of 99.02% and a public holding of 0.98%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Prasitraj Associates LlpActive 14 years 5 monthsAnita Jakhete and Prashant Jakhete are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Renentech Laboratories?
Renentech Laboratories has a workforce of 24 employees as of Apr 05, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Renentech Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Renentech Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
